SynCore Biotechnology to Participate at the BIO-Europe 2017 – 23rd Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the [...]
SynCore Bio is selected to present the Phase I study data of new anti-cancer molecule SB01 at ASCO 2017
SynCore Bio is selected to present the Phase I [...]
2017 Sinphar Bio-Forum – Cardiovascular Disease Management
On January 13th of this year, Sinphar Group held [...]